Tag:
Auxogyn
Latest Headlines
Latest Headlines
Auxogyn reels in $18M to fuel IVF/embryo viability test
Auxogyn has reeled in $18 million in Series B funding to help bring its diagnostic test to evaluate embryo viability during in vitro fertilization to the regulatory finish line in a big advance for the field.
Kleiner Perkins to back early-stage biotechs with $525M fund
Kleiner Perkins Caulfield & Byers has closed the books on a new $525 million fund. And a chunk of that treasure is earmarked for early-stage life science companies.
